A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)

Clinical trial NCT05038800 · TERMINATED

Trial details

NCT number: NCT05038800
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Acute Myeloid Leukemia Relapsed or Refractory Chronic Myelomonocytic Leukemia

Start date: 2021-09-26
Primary completion: 2023-12-11
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.